Evertis launches Evercare brand, set to be a leading provider of specialty and innovative medical-grade films designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare draws on over 65 years of technical expertise from Evertis in PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.
Evercare sits in a vertically integrated Group that delivers a unique value proposition to healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis, a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.
Evercare PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.
Gonzalo Lopez-Oleaga, Evertis Europe deputy CEO said, “This is another key milestone in the journey of our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market.”
Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug & play recyclable PET based solutions but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.
Casimiro Sacchetti, CSO Evertis Americas said, “It’s an exciting and unique offering for the healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”
